Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aytu Biopharma (AYTU) Prepaid Assets (2016 - 2025)

Aytu Biopharma (AYTU) has disclosed Prepaid Assets for 14 consecutive years, with $6.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Prepaid Assets rose 7.62% to $6.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $6.6 million, a 7.62% increase, with the full-year FY2025 number at $5.6 million, up 10.61% from a year prior.
  • Prepaid Assets was $6.6 million for Q4 2025 at Aytu Biopharma, up from $5.2 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $71.1 million in Q2 2023 to a low of $633000.0 in Q2 2022.
  • A 5-year average of $8.0 million and a median of $5.2 million in 2025 define the central range for Prepaid Assets.
  • Peak YoY movement for Prepaid Assets: surged 11128.91% in 2023, then tumbled 92.83% in 2024.
  • Aytu Biopharma's Prepaid Assets stood at $11.3 million in 2021, then grew by 6.12% to $12.0 million in 2022, then crashed by 88.88% to $1.3 million in 2023, then soared by 362.64% to $6.2 million in 2024, then increased by 7.62% to $6.6 million in 2025.
  • Per Business Quant, the three most recent readings for AYTU's Prepaid Assets are $6.6 million (Q4 2025), $5.2 million (Q3 2025), and $5.6 million (Q2 2025).